|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/00 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 37/04 |
| (11) | Patento numeris | 3027650 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14748185.7 |
| Europos patento paraiškos padavimo data | 2014-08-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-06-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/066650 |
| Data | 2014-08-01 |
| (87) | Numeris | WO 2015/015003 |
| Data | 2015-02-05 |
| (30) | Numeris | Data | Šalis |
| 13178958 | 2013-08-01 | EP | |
| 201361861008 P | 2013-08-01 | US | |
| 14167425 | 2014-05-07 | EP |
| (72) |
LUCAS, Sophie, BE
COULIE, Pierre, BE
CUENDE VILLASUR, Julia, BE
DUMOUTIER, Laure, BE
RENAULD, Jean-Christophe, BE
VAN DER WONING, Sebastian, BE
SAUNDERS, Michael, BE
DE HAARD, Hans, NL
DE BOECK, Gitte, BE
|
| (73) |
Ludwig Institute for Cancer Research Ltd,
Stadelhoferstrasse 22, 8001 Zürich,
CH
Université catholique de Louvain, Place de l`Université 1, 1348 Louvain-la-Neuve, BE argenx BVBA, Industriepark 7, 9052 Zwijnaarde, BE |
| (54) | ANTIBODY BINDING A COMPLEX OF HUMAN GLYCOPROTEIN A REPETITIONS PREDOMINANT (GARP) AND LATENT TGF-BETA-1 |
| ANTIBODY BINDING A COMPLEX OF HUMAN GLYCOPROTEIN A REPETITIONS PREDOMINANT (GARP) AND LATENT TGF-BETA-1 |